Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stock Incentive Plan (Details Textual)

v3.24.3
Note 5 - Stock Incentive Plan (Details Textual)
3 Months Ended 9 Months Ended
Aug. 05, 2024
shares
Mar. 31, 2022
shares
Apr. 30, 2020
shares
Sep. 30, 2024
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
Jun. 30, 2023
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
Aug. 12, 2024
shares
Jun. 30, 2024
shares
Oct. 31, 2017
shares
Apr. 30, 2016
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) [1]             43,523          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $       $ 553,205     $ 553,205          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $       $ 131,509     $ 131,509          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares       $ 19.35     $ 19.35          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares       21.92     21.92          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares       $ 11.38     $ 11.38          
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $       $ 1,400,000     $ 1,400,000          
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)             2 years          
Share-Based Payment Arrangement, Expense, Tax Benefit | $             $ 0          
General and Administrative Expense [Member]                        
Share-Based Payment Arrangement, Expense | $       13,512 $ 256,670   325,589 $ 757,303        
Research and Development Expense [Member]                        
Share-Based Payment Arrangement, Expense | $       $ 185,609 $ 217,468   $ 536,584 $ 666,340        
Vesting Monthly Over One Year [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)             2,000          
Vesting 6/48ths on Six-months and 1/48th After [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)             41,523          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) 7,100,000 1,020,000 620,000           1,420,000 5,100,000 320,000 140,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares)   400,000 300,000                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)           0            
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)             5,997          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)             10 years 10 years        
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Officer [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)             30,001          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)             4 years          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Officer [Member] | Minimum [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share) | $ / shares       $ 2.45     $ 2.45          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Officer [Member] | Maximum [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share) | $ / shares       2.956     $ 2.956          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Non-officer Employees [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)             11,522          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)             4 years          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Non-officer Employees [Member] | Minimum [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share) | $ / shares       1.899     $ 1.899          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Non-officer Employees [Member] | Maximum [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share) | $ / shares       2.751     $ 2.751          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Options Held [Member] | Share-Based Payment Arrangement, Option [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)             2,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share) | $ / shares       $ 1.271     $ 1.271          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)             12 months          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Reverse Stock Split [Member]                        
Stockholders' Equity Note, Stock Split, Conversion Ratio 5                      
Monopar Therapeutics Inc. 2016 Amended Stock Incentive Plan [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) 1,420,000 1,020,000                    
[1] 78,592 options vest as follows: options to purchase 10,000 shares of the Company’s common stock vest monthly over one year; options to purchase 68,592 shares of the Company's common stock vest 6/48ths on the six-month anniversary of vesting commencement date and 1/48th per month thereafter.